Clinical trial
Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral…
NCT00356720 · Laboratoires Thea, Industry · Completed
Key facts
| NCT number | NCT00356720 |
|---|---|
| Title | Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma |
| Official title | Clinical Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% (Instilled Twice Daily for 2 or 3 Days) Versus Oral Azithromycin in Treatment of Trachoma |
| Lead sponsor | Laboratoires Thea, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Trachoma |
| Intervention type | Drug |
| Interventions | Azithromycin |
| Start date | Jan 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Jul 26, 2006 |
| Last update posted | Jul 26, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: